Subscribe Now

By entering these details you are signing up to receive our newsletter.

Events

Reuters Events: Pandemic Prevention

How Europe can lead the fight against AMR

The COVID-19 pandemic took the world by surprise. An AMR induced pandemic will not. New business models, investment into antimicrobials R&D, and reducing dependence on antibiotics are all part of the strategy required to tackle AMR, in 2022 and beyond.

This online event, an EFPIA initiative, in collaboration with Reuters Events, brings together experts from BEAM, AMR Action Fund, Carb-X, CRA, EFPIA, European Patients Forum (EPF) and more for a conversation on how public institutions and stakeholders can work together to find sustainable solutions to support antimicrobial pipelines.

Join us for this timely virtual event Pandemic Prevention: how Europe can lead the fight against AMR, on 16 November at 14:00-15:30 CET, to discuss how we can drive investment in antimicrobials R&D and set out a roadmap to a sustainable innovation ecosystem that will safeguard society against the threat of AMR.

Gain thought-provoking insights from leaders, including:

  • Juan Jose Fernandez Romero, Policy Assistant, European Patients Forum (EPF)
  • Mark Jones, Head of Preclinical Development and Clinical Project Management, Basilea; Board Member, BEAM Alliance & Swiss Round Table for Antibiotics Alliance
  • Prof. Kevin Outterson, Professor and Executive Director, Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X)
  • Kristine Peers, General Counsel, EFPIA
  • Dr. Henry Skinner, CEO, AMR Action Fund

Key themes you will gain insight into:

  • Deliver innovation incentives to create a sustainable ecosystem to meet the needs of today and tomorrow’s patients
  • Identify which reforms are most needed on an EU and Country level to build a pipeline for future antibiotics
  • What does success look like? Hear thoughts on what needs to be agreed in 2022 to meet the EC’s mandate for change

Join the event, an EFPIA initiative, organised in collaboration with Reuters Events, to learn how we can drive investment in antimicrobials R&D and set out a roadmap to a sustainable innovation ecosystem that will safeguard society against the threat of AMR.

Skip to content